48 related articles for article (PubMed ID: 14520705)
1. Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age.
Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Daling JR
Int J Cancer; 2003 Nov; 107(4):647-51. PubMed ID: 14520705
[TBL] [Abstract][Full Text] [Related]
2. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.
Arpino G; Bardou VJ; Clark GM; Elledge RM
Breast Cancer Res; 2004; 6(3):R149-56. PubMed ID: 15084238
[TBL] [Abstract][Full Text] [Related]
3. Is There a Special Role for Ovarian Hormones in the Pathogenesis of Lobular Carcinoma?
Flaherty RL; Sflomos G; Brisken C
Endocrinology; 2024 Mar; 165(5):. PubMed ID: 38551031
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer.
Record H; Clelland E; Rothschild HT; Kaur M; Chien AJ; Melisko M; Rugo HS; Mujir F; Huppert L; Mukhtar RA
NPJ Breast Cancer; 2023 Oct; 9(1):88. PubMed ID: 37884561
[TBL] [Abstract][Full Text] [Related]
5. Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes.
Kaur M; Patterson A; Molina-Vega J; Rothschild H; Clelland E; Ewing CA; Mujir F; Esserman LJ; Olopade OI; Mukhtar RA
Cancer Epidemiol Biomarkers Prev; 2023 Aug; 32(8):1107-1113. PubMed ID: 37257200
[TBL] [Abstract][Full Text] [Related]
6. The association of body mass index and adverse clinicopathological characteristics in non-metastatic breast cancer.
Abusanad A; Alghamdi B; Alghamdi R; Khallaf R; Faisal K; Bishnaq R
J Family Med Prim Care; 2020 Aug; 9(8):4190-4195. PubMed ID: 33110830
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis.
Han Y; Wang J; Xu B
Breast; 2020 Dec; 54():114-120. PubMed ID: 32979771
[TBL] [Abstract][Full Text] [Related]
8. The effect of length of birth interval on the risk of breast cancer by subtype in grand multiparous women.
Katuwal S; Tapanainen JS; Pukkala E; Kauppila A
BMC Cancer; 2019 Mar; 19(1):199. PubMed ID: 30832620
[TBL] [Abstract][Full Text] [Related]
9. Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study.
Williams LA; Nichols HB; Hoadley KA; Tse CK; Geradts J; Bell ME; Perou CM; Love MI; Olshan AF; Troester MA
Cancer Causes Control; 2018 Jan; 29(1):25-32. PubMed ID: 29124544
[TBL] [Abstract][Full Text] [Related]
10. Potential Mechanisms underlying the Protective Effect of Pregnancy against Breast Cancer: A Focus on the IGF Pathway.
Katz TA
Front Oncol; 2016; 6():228. PubMed ID: 27833901
[TBL] [Abstract][Full Text] [Related]
11. PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma.
Boelens MC; Nethe M; Klarenbeek S; de Ruiter JR; Schut E; Bonzanni N; Zeeman AL; Wientjens E; van der Burg E; Wessels L; van Amerongen R; Jonkers J
Cell Rep; 2016 Aug; 16(8):2087-2101. PubMed ID: 27524621
[TBL] [Abstract][Full Text] [Related]
12. Lobular breast cancer: incidence and genetic and non-genetic risk factors.
Dossus L; Benusiglio PR
Breast Cancer Res; 2015 Mar; 17():37. PubMed ID: 25848941
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk in older women: results from the NIH-AARP Diet and Health Study.
Brinton LA; Smith L; Gierach GL; Pfeiffer RM; Nyante SJ; Sherman ME; Park Y; Hollenbeck AR; Dallal CM
Cancer Causes Control; 2014 Jul; 25(7):843-57. PubMed ID: 24810653
[TBL] [Abstract][Full Text] [Related]
14. Do reproductive factors influence T, N, and M classes of ductal and lobular breast cancers? A nation-wide follow-up study.
Mousavi SM; Försti A; Sundquist K; Hemminki K
PLoS One; 2013; 8(5):e58867. PubMed ID: 23734170
[TBL] [Abstract][Full Text] [Related]
15. Impact of menstrual and reproductive factors on breast cancer risk in Tunisia: a case-control study.
Msolly A; Gharbi O; Ben Ahmed S
Med Oncol; 2013 Mar; 30(1):480. PubMed ID: 23377925
[TBL] [Abstract][Full Text] [Related]
16. Absence of the K303R estrogen receptor α mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment.
Ghimenti C; Mello-Grand M; Regolo L; Zambelli A; Chiorino G
Exp Ther Med; 2010 Nov; 1(6):939-942. PubMed ID: 22993622
[TBL] [Abstract][Full Text] [Related]
17. Leg length, sitting height and postmenopausal breast cancer risk.
Mellemkjær L; Christensen J; Frederiksen K; Baker JL; Olsen A; Sørensen TI; Tjønneland A
Br J Cancer; 2012 Jun; 107(1):165-8. PubMed ID: 22677900
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry.
Work ME; Andrulis IL; John EM; Hopper JL; Liao Y; Zhang FF; Knight JA; West DW; Milne RL; Giles GG; Longacre TA; O'Malley F; Mulligan AM; Southey MC; Hibshoosh H; Terry MB
Breast Cancer Res Treat; 2012 Aug; 134(3):1209-20. PubMed ID: 22527103
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer.
Madeleine MM; Johnson LG; Malkki M; Resler AJ; Petersdorf EW; McKnight B; Malone KE
Breast Cancer Res Treat; 2011 Oct; 129(3):887-99. PubMed ID: 21523452
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
